CLSI M2 A12 : 12ED 2015

Abstract
Committee Membership
Foreword
Summary of Changes
Summary of CSLI Processes for Establishing Interpretive
Criteria and Quality Control Ranges
CLSI References Methods vs Commercial Methods
and CLSI vs US Food and Drug Administration
Interpretive Criteria (Breakpoints)
Subcommittee on Antimicrobial Susceptibility Testing
Mission Staement
Chapter 1 - Introduction
Chapter 2 - Indications for Performing Susceptibility Tests
Chapter 3 - Susceptibility Testing Process
Chapter 4 - Quality Control and Quality Assurance
Chapter 5 - Conclusion
Chapter 6 - Supplemental Information
References
Appendix A - Quality Control Protocol Flow Charts
Appendix B - Preparation of Media and Reagents
Appendix C - Conditions for Disk Diffusion Antimicrobial
             Susceptibility Tests
Appendix D - Quality Control Strains for Anitmicrobial
             Susceptibility Tests (refer to current edition of M100[1]
             for the most current version of this table)
Appendix E - Qulity Control Strain Maintenance (also refer to
             Subchapter 4.4)
The Quality Management System Approach
Related CLSI Reference Materials

Describes the current Clinical and Laboratory Standards Institute-recommended methods for disk susceptibility testing, criteria for quality control testing, and updates tables for interpretive zone diameters.